摘要
目的建立LC/MS/MS法测定人尿中的秋水仙碱浓度,初步研究人体口服秋水仙碱片剂后的排泄规律。方法色谱柱:Agilent Eclipse XDB C18柱,流动相:甲醇-10 mmol.L-1乙酸铵(60∶40),以ESI源正离子MRM模式测定。结果线性范围为3~3000 ng.mL-1(γ=0.9978),相对回收率为91.6%~93.7%,日内、日间变异(RSD)均<15%,基质效应为80.9%~90.9%。服药24,96 h后的原药平均累积尿排率分别为15.2%和20.9%。结论本方法适于秋水仙碱的尿药浓度测定,其在人体内仅经尿液排泄少部分原药。
Objective To develop a LC/MS/MS method for the determination of colchicine in human urine and study on its excretion.Methods Human urine samples,collected from 2 healthy volunteers were selected to fasting oral 1 mg colchicine tablet,added with scopolamine hydrobromide as internal standard,diluted by mobile phase solution,then measured by LC/MS/MS.Used the Agilent Eclipse XDB C18 as analytical column,and the mobile phase consisted of methanol-10 mmol·L-1 NH4AC buffer(60∶40).The urine concentrations were detected in ESI positive MRM mode.Results The good linear range of colchicine was 3-3000 ng·mL-1(γ=0.9978).The recovery was 91.6%-93.7%,and matrix effects was 80.9%-90.9%.The within-day and between-day deviations were less than 15%.The result showed that the mean urinary excretion percentage of colchicine after 24 h and 96 h were 15.2% and 20.9%,respectively.Conclusion The method suitable for determination of colchicine in human urine and clinical pharmacokinetic study.The drug only excreted small part through kidney in human in form of colchicine.
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2012年第1期59-61,66,共4页
The Chinese Journal of Clinical Pharmacology
基金
科技部重大新药创制专项基金资助项目(2008ZX09312-021)